MiMedx appoints CCO

Jul 25, 2018
Mark Graves was most recently a senior official with UCB
Biopharmaceutical firm MiMedx Group has appointed Mark Graves as chief compliance officer (CCO). In his new role, he will be responsible for providing direction and oversight of MiMedx's compliance program, including the company's regulatory and legal compliance

Content Preview

to continue reading

  • All articles online
  • Newsletter
Sign up to get stories direct to your inbox
Cs logo Cs logo